What is the treatment for sickle cell disease in the children?

Question

Hi doctor,

I want a detailed explanation of sickle cell disease in children, focusing on symptoms and anemia treatment. Could you elaborate on the difficulties kids with sickle cell anemia encounter, such as any possible complications and how it affects their day-to-day activities? I would also like to know about the most recent developments in pediatric patient-specific treatment alternatives, such as innovative medicines or supporting measures to enhance the patient's quality of life and long-term results.

Please help.

Thanks.

Answer 1

Hi,

Welcome to icliniq.com.

I understand your concern.

Sickle cell disease (SCD) is a genetic disorder characterized by abnormal hemoglobin, known as hemoglobin S (HbS), in red blood cells. This abnormal hemoglobin causes red blood cells to become rigid and assume a sickle or crescent shape, leading to various complications. The spleen destroys this kind of cell and leads to anemia. SCD is typically diagnosed in infancy through newborn screening or early childhood. The hallmark symptom of SCD is anemia, which occurs due to the premature destruction of sickle-shaped red blood cells in the spleen. Anemia can cause fatigue, weakness, and pale skin.

Children with SCD often experience episodes of severe pain, known as pain crises or vaso-occlusive crises. These crises occur when sickle-shaped red blood cells block blood flow to organs and tissues, leading to tissue damage and intense pain. Pain crises can occur anywhere in the body but commonly affect the bones, joints, chest, and abdomen. Spleen destruction of RBC liberates bilirubin and causes jaundice, a yellowing of the skin and eyes.

Children with SCD are at an increased risk of bacterial infections, particularly those caused by encapsulated bacteria such as Streptococcus pneumoniae. These infections can be severe and potentially life-threatening. Chronic anemia and complications such as pain crises can impact a child's growth and development. Serious complications of SCD are characterized by chest pain, fever, cough, and shortness of breath. It can be triggered by infection or vaso-occlusion in the lungs, leading to respiratory failure if not treated promptly. Children with SCD are at an increased risk of stroke due to impaired blood flow to the brain caused by sickle-shaped red blood cells. Children with severe anemia or complications such as acute chest syndrome may require blood transfusions to increase their hemoglobin levels and improve oxygen delivery to tissues.

Hydroxyurea is a medication that can help reduce the frequency and severity of pain crises and acute chest syndrome in children with SCD. It works by increasing the production of fetal hemoglobin, which is less prone to sickling. Folic acid supplementation is often recommended for children with SCD to support red blood cell production. Pain crises are managed with pain medications such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and supportive measures such as hydration and heat therapy. Recent developments in pediatric patient-specific treatment, such as gene therapy, stem cell transplantation, novel medications, or supportive care, are promising. Children with SCD need to receive comprehensive, multidisciplinary care from a team of healthcare providers experienced in managing the complexities of the disease.

I hope this information will help you.

Thanks.